The behavior of mafenide acetate as a basis for its clinical use.
D000818:Animals; D002056:Burns / Q000150:complications*; D002247:Carbon Isotopes; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D010210:Papillary Muscles / Q000378:metabolism; D011485:Protein Binding; D011552:Pseudomonas Infections / Q000517:prevention & control; D051381:Rats; D018805:Sepsis / Q000517:prevention & control*; D013449:Sulfonamides / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D014050:Toluene; D014946:Wound Infection / Q000517:prevention & control*
D002247:Carbon Isotopes; D013449:Sulfonamides; D014050:Toluene